## Abstract The aim of this prospective study was to obtain the first human safety and magnetic resonance (MR) imaging results with a new formulation of superparamagnetic iron oxide (SPIO) (SHU 555 A). The SPIO was tested at four iron doses, from 5 to 40 ΞΌmol/kg. Laboratory tests and clinical measu
Iron oxide-enhanced MR imaging of the liver and spleen: review of the first 5 years.
β Scribed by Ferrucci, J T; Stark, D D
- Book ID
- 121280348
- Publisher
- American Roentgen Ray Society
- Year
- 1990
- Tongue
- English
- Weight
- 616 KB
- Volume
- 155
- Category
- Article
- ISSN
- 0361-803X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The purpose of this study was to determine the dependency of liver-and spleen-enhancement on particle size and dose of bolus-injectable iron oxides designed for bloodpool MR-angiography (MRA). The superparamagnetic iron oxide SHU 555 A [particle size 65 nm (group 1)] and three derivatives designed f
## Abstract Small nodular lesions in the liver and spleen have been reported as an infrequent manifestation of sarcoidosis. Five patients with this appearance on either dynamic contrast materialβenhanced computed tomographic (CT) or ultrasound scans underwent magnetic resonance (MR) imaging with an